Stein Jacobsen
CIK 1452830 · View on SEC EDGAR ↗
First SEC filing: Jan. 6, 2009 · Latest: Jan. 6, 2009
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 23, 2011 | RMD | S | 9,196 | $25.28 | $232,475 | 52,143 Direct | -14.99% | Disposed | 802.0% (price as of 2026-08-19) |
| Nov. 12, 2010 | RMD | S | 10,222 | $33.24 | $339,779 | 30,001 Direct | -25.41% | Disposed | 586.0% (price as of 2026-08-19) |
| Nov. 12, 2010 | RMD | S | 10,000 | $33.25 | $332,500 | 40,223 Direct | -19.91% | Disposed | 585.8% (price as of 2026-08-19) |
| Nov. 12, 2010 | RMD | S | 6,000 | $33.25 | $199,500 | 40,223 Direct | -12.98% | Disposed | 585.8% (price as of 2026-08-19) |
| Nov. 12, 2010 | RMD | S | 37,500 | $33.21 | $1,245,375 | 40,223 Direct | -48.25% | Disposed | 586.6% (price as of 2026-08-19) |
| Nov. 12, 2010 | RMD | S | 24,000 | $33.25 | $798,000 | 40,223 Direct | -37.37% | Disposed | 585.8% (price as of 2026-08-19) |
| Feb. 12, 2010 | RMD | S | 17,500 | $55.67 | $974,225 | 2,376 Direct | -88.05% | Disposed | 719.2% (price as of 2026-08-19) |
| Feb. 12, 2010 | RMD | S | 12,000 | $55.65 | $667,800 | 2,376 Direct | -83.47% | Disposed | 719.5% (price as of 2026-08-19) |
| Nov. 17, 2009 | RMD | S | 40,000 | $50.00 | $2,000,000 | 0 Indirect | -100.00% | Disposed | 812.1% (price as of 2026-08-19) |
| Aug. 10, 2009 | RMD | S | 22,000 | $45.02 | $990,440 | 2,050 Direct | -91.48% | Disposed | 913.0% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 12, 2010 | RMD | ResMed Common Stock Options | ResMed Common Stock (10,000) | $21.68 | Oct. 1, 2015 | 10,000 | Disposed |
| Nov. 12, 2010 | RMD | ResMed Common Stock Options | ResMed Common Stock (6,000) | $21.02 | Nov. 7, 2014 | 6,000 | Disposed |
| Nov. 12, 2010 | RMD | ResMed Common Stock Options | ResMed Common Stock (37,500) | $21.71 | Aug. 1, 2014 | 37,500 | Disposed |
| Nov. 12, 2010 | RMD | ResMed Common Stock Options | ResMed Common Stock (24,000) | $23.10 | Nov. 10, 2013 | 24,000 | Disposed |
| Feb. 12, 2010 | RMD | ResMed Common Stock Options | ResMed Common Stock (17,500) | $31.04 | Nov. 20, 2015 | 17,500 | Disposed |
| Feb. 12, 2010 | RMD | ResMed Common Stock Options | ResMed Common Stock (12,000) | $38.50 | Feb. 3, 2016 | 12,000 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 6, 2009 | RMD | ResMed Common Stock | 23,699 | Direct |
| Jan. 6, 2009 | RMD | ResMed Common Stock | 40,000 | Indirect |
| Jan. 6, 2009 | RMD | ResMed Common Stock Options→ ResMed Common Stock (12,000) | 12,000 | Direct |
| Jan. 6, 2009 | RMD | ResMed Common Stock Options→ ResMed Common Stock (12,000) | 12,000 | Direct |
| Jan. 6, 2009 | RMD | ResMed Common Stock Options→ ResMed Common Stock (25,000) | 25,000 | Direct |
| Jan. 6, 2009 | RMD | ResMed Common Stock Options→ ResMed Common Stock (4,000) | 4,000 | Direct |
| Jan. 6, 2009 | RMD | ResMed Common Stock Options→ ResMed Common Stock (10,000) | 10,000 | Direct |
| Jan. 6, 2009 | RMD | ResMed Common Stock Options→ ResMed Common Stock (70,000) | 70,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2012 | $300,487 | — | $1,260,820 | $0 | $223,314 | — | $575,825 | $1,099,626 |
| 2011 | $373,983 | — | — | — | $274,485 | — | $90,415 | $2,183,164 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.